Concepedia

Melphalan Dosing

Melphalan Dosing is a pharmacotherapeutic protocol that specifies the precise administration regimen of melphalan, a bifunctional alkylating agent, in the context of conditioning prior to bone marrow transplantation, differentiated by its reliance on patient-specific factors such as body surface area, renal function, and transplant indication to optimize myeloablation while minimizing toxicity.

448

Publications

23.2K

Citations

2.9K

Authors

862

Institutions

Publications per year

2017–2026

44

Parents

Publications

448

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

Martha Skinner, Vaishali Sanchorawala, David C. Seldin et al. · Annals of Internal Medicine · 2004 · 615 citations

, , +14

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer

Robert C. Young, Leslie A. Walton, Susan S. Ellenberg et al. · New England Journal of Medicine · 1990 · 593 citations · Full text

, , +16

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond et al. · New England Journal of Medicine · 2007 · 518 citations

, , +14

HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA

T MCELWAIN · The Lancet · 1983 · 512 citations

, , +10

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Antonio Palumbo, Sara Bringhen, Anna Marina Liberati et al. · Blood · 2008 · 357 citations · Full text

, , +15

1–5 of 448

Authors

2.9K

  1. VS
    Vaishali Sanchorawala

    Boston University, United States

    25 publications · 2.5K citations

    19

    h-index

  2. DC
    David C. Seldin

    Boston University, United States

    17 publications · 1.9K citations

    15

    h-index

  3. MB
    Mario Boccadoro

    University of Turin, Italy

    17 publications · 1.3K citations

    14

    h-index

  4. KQ
    Karen Quillen

    Boston University, United States

    13 publications · 1.6K citations

    12

    h-index

  5. MS
    Martha Skinner

    Boston University, United States

    12 publications · 1.9K citations

    12

    h-index

1–5 of 2.9K

Institutions

862

  1. Boston University

    Boston, United States

    17 h-index

    155 publications

    19.9K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    15 h-index

    100 publications

    3.5K citations

  3. Royal Marsden NHS Foundation Trust

    London, United Kingdom

    13 h-index

    64 publications

    4.2K citations

  4. Boston Medical Center

    Boston, United States

    13 h-index

    93 publications

    10.3K citations

  5. The University of Texas MD Anderson Cancer Center

    Houston, United States

    13 h-index

    93 publications

    4.2K citations

  6. Royal Marsden Hospital

    London, United Kingdom

    13 h-index

    62 publications

    2.9K citations

  7. Mayo Clinic in Arizona

    Scottsdale, United States

    12 h-index

    75 publications

    2.8K citations

  8. Azienda Ospedaliero Universitaria San Giovanni Battista

    Turin, Italy

    12 h-index

    110 publications

    12.7K citations

1–8 of 862

Venues

  1. Blood

    60 publications · 5K citations

    33

    h-index

  2. Bone Marrow Transplantation

    54 publications · 2.1K citations

    28

    h-index

  3. PubMed

    Repository · 53 publications · 1.9K citations

    27

    h-index

  4. Journal of Clinical Oncology

    21 publications · 2K citations

    17

    h-index

  5. Cancer Chemotherapy and Pharmacology

    20 publications · 583 citations

    16

    h-index

1–5